Quantitative Assessment of Hypoxia Kinetic Models by a Cross-Study of Dynamic 18F-FAZA and 15O-H2O in Patients with Head and Neck Tumors

Several kinetic models have been proposed to assess the underlying oxygenation status behind hypoxia tracer uptake and have shown advantages, compared with static analysis, in discriminating hypoxic regions. However, the quantitative assessment of mathematic models that take into consideration clinical applications and their biologic nature is still challenging. We performed a feasibility study to assess hypoxia kinetic models using voxelwise cross-analysis between the uptake of the perfusion tracer 15O-H2O and the hypoxia tracer 18F-fluoroazomycin arabinoside (18F-FAZA). Methods: Five patients with advanced head and neck cancer were included. For each patient, dynamic sequences of 15O-H2O for 5 min and 18F-FAZA for 60 min were acquired consecutively after injections of approximately 1 GBq and 300 MBq of each tracer, respectively. The compartment model, Thorwarth model, Patlak plot, Logan plot, and Cho model were applied to model the process of tracer transport and accumulation under hypoxic conditions. The standard 1-tissue-compartment model was used to compute a perfusion map for each patient. The hypoxia kinetic models were based on the assumption of a positive correlation between tracer delivery and perfusion and a negative (inverse) correlation between tracer accumulation (hypoxia) and perfusion. Results: Positive correlations between tracer delivery and perfusion were observed for the Thorwarth and Cho models in all patients and for the reversible and irreversible 2-compartment models in 4 patients. Negative correlations between tracer accumulation and perfusion were observed for the reversible 2-compartment model in all patients and for the irreversible 2-compartment model and Cho model in 4 patients. When applied to normal skeletal muscle, the smallest correlation variance over all 5 patients was observed for the reversible 2-compartment model. Conclusion: Hypoxia kinetic modeling delivers different information from static measurements. Different models generate different results for the same patient, and they even can lead to opposite physiologic interpretations. On the basis of our assessment of physiologic precision and robustness, the reversible 2-compartment model corresponds better to the expectations of our assumptions than the other investigated models.

[1]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Daniela Thorwarth,et al.  A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia , 2005, Physics in medicine and biology.

[3]  J. Bussink,et al.  Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy. , 2008, International journal of radiation oncology, biology, physics.

[4]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[5]  David Dagan Feng,et al.  An evaluation of the algorithms for determining local cerebral metabolic rates of glucose using positron emission tomography dynamic data , 1995, IEEE Trans. Medical Imaging.

[6]  C. Ling,et al.  In vivo characterization of a reporter gene system for imaging hypoxia-induced gene expression. , 2009, Nuclear medicine and biology.

[7]  Michael Höckel,et al.  Detection and characterization of tumor hypoxia using pO2 histography. , 2007, Antioxidants & redox signaling.

[8]  M. Picchio,et al.  Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  P. Vaupel Pathophysiology of Solid Tumors , 2009 .

[10]  John L. Humm,et al.  Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging , 2008, Physics in medicine and biology.

[11]  Y. Fujibayashi,et al.  Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone). , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[13]  Tove Grönroos,et al.  Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. , 2004, International Journal of Radiation Oncology, Biology, Physics.

[14]  T K Lewellen,et al.  Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.

[15]  P. Vaupel Physiological Mechanisms of Treatment Resistance , 2009 .

[16]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[17]  D. Feng,et al.  Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. , 1993, International journal of bio-medical computing.

[18]  Ronald Boellaard,et al.  Optimization algorithms and weighting factors for analysis of dynamic PET studies , 2006, Physics in medicine and biology.

[19]  Barbara Kaser-Hotz,et al.  Measurement of tumor hypoxia in spontaneous canine sarcomas. , 2005, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[20]  C Clifton Ling,et al.  Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET. , 2009, Medical physics.

[21]  M E Phelps,et al.  Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[23]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  S. Gunn,et al.  Positron Emission Tomography Compartmental Models , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  S. Ametamey,et al.  Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  V. Oikonen,et al.  Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  M. Dewhirst,et al.  Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.

[28]  U Ruotsalainen,et al.  Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  C. Ling,et al.  Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia. , 2009, Neoplasia.

[30]  T W Griffin,et al.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.

[31]  M. Graham,et al.  A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. , 1995, Medical physics.

[32]  Morand Piert,et al.  Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  P Vaupel,et al.  Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.

[34]  I Kanno,et al.  Noninvasive quantitation of cerebral blood flow using oxygen-15-water and a dual-PET system. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  M. Alber,et al.  Imaging oxygenation of human tumours , 2006, European Radiology.

[36]  Mark Lubberink,et al.  Reproducibility of Tumor Perfusion Measurements Using 15O-Labeled Water and PET , 2008, Journal of Nuclear Medicine.